Stock Ratings / Health Care / ACIU / insiders

CAMP (34) VNDA (37) LFCR (51) ELDN (49) ⌘ Pro Terminal →

AC Immune SA (ACIU) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$2.37 0.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.37

AC Immune SA (ACIU) carries a Roarable Rating of D+ (Sell) with 52/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record: Scores of 52/100 (D+) historically posted market-perform odds over rolling 90-day windows (-1.1% avg 90D alpha vs SPY) →

ROARABLE D+ • SELL / AVOID Cap $241.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.37 (-0.19%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.2% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 52/100 (D+) historically posted market-perform odds over rolling 90-day windows (-1.1% avg 90D alpha vs SPY • 50.1% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D+

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-2.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ACIU)Realized 20D OHLCV Swing Band: ±10.5%

Deterministic 5-Pillar Attribution (52/100 Composite)

🔍 WHY ACIU SCORES 52/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (25% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (23% of score)

SEC XBRL Trailing 12 Months: 0.2% FCF Margin ($6.8M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning8/20 pts (-12 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C$2.50-4.4% Next Q

Q2 (-2Q)

Grade C$2.39+1.3% Next Q

Q3 (-1Q)

Grade C$2.42-2.1% Next Q

Current

Grade D+$2.37-1.1% Hist 90D α

Trajectory: C (60) → D+ (52)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ACIU Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ACIU currently carries a cautious 52/100 (D+) rating due to Whale & Options Positioning (8/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.61) and Max Pain ($2.49) forces dealer call-delta covering toward $4.09.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ACIU• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “ACIU Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 52%NO 48%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

ACIU Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (ACIU)

No recent open-market Form 4 cluster sales or emergency dumps flagged on ACIU. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ACIU)

✓Walkthrough of ACIU's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ACIU // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -21.78%▼ DESCENDING CHANNEL

2026-10-30O $2.37H $2.37L $2.21C $2.37VOL 105.1K

RES: $2.92SUP: $2.03SMA50: $2.61SMA200: $2.73

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ACIU Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ACIU Butterfly Map → + Track ACIU →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ACIU today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ACIU. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ACIU today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ACIU)

Health Care Rank #322 of 1016 ⚔️ CAMP vs ACIU Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ACIU vs. CAMP, VNDA, LFCR, ELDN)

Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, AC Immune SA (ACIU) ranks #322 by composite RQD confidence (52/100, grade D+) and #554 by equity capitalization ($241.2M). Within this direct 5-issuer industry benchmark cohort, ACIU leads on earnings valuation at N/A trailing P/E, while CAMP leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. ACIU currently leads its immediate peer cohort in composite quantitative strength at 52/100 (D+).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ACIU ACTIVE AC Immune SA	D+	52/100	—	—	—	0.00%	$241.2M	Benchmark Subject
CAMP CAMP4 Therapeutics Corporation	E	34/100	—	—	-35.0%	+6.85%	$244.7M	/camp-vs-aciu →
VNDA Vanda Pharmaceuticals Inc.	D-	37/100	—	—	-35.0%	+1.25%	$244.9M	/vnda-vs-aciu →
LFCR Lifecore Biomedical Inc.	D	51/100	—	—	—	+0.15%	$246.8M	/lfcr-vs-aciu →
ELDN Eledon Pharmaceuticals Inc.	D	49/100	—	—	-35.0%	+10.15%	$247.0M	/eldn-vs-aciu →

2. ACIU Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

AC Immune SA (ACIU) operates in Biotechnology: Pharmaceutical Preparations (Health Care) with an equity capitalization of $241.2M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. ACIU Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ACIU stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, AC Immune SA (NASDAQ: ACIU) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 52/100 at a spot price of $2.37 (0.00% 1D, market cap $241.2M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, ACIU ranks #322 in composite RQD confidence.

How does ACIU compare to CAMP and VNDA in the Health Care sector?

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), ACIU carries a Roarable D+ (52/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, CAMP (CAMP4 Therapeutics Corporation) holds a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $244.7M) and VNDA (Vanda Pharmaceuticals Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $244.9M). Among the 5-stock peer group, ACIU leads on earnings multiple (N/A) while CAMP leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ACIU?

For AC Immune SA (ACIU), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #322 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ACIU trading relative to its 50-day, 200-day, and 52-week technical levels?

ACIU last traded at $2.37 (0.00% on volume of 105,229 shares), positioning the stock -9.20% below its 50-day simple moving average ($2.61) and -13.19% below its 200-day simple moving average ($2.73). Across its 52-week range of $2.03 to $3.90, ACIU sits at the 18.2% percentile with a 14-day RSI of 36.2 (NEUTRAL RANGE) and an implied next-earnings move of ±10.5% ($2.12 to $2.62).

ACIU Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are ACIU insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies ACIU leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.

Direct Sub-Reports: ACIU RQD Cockpit ACIU 12M Forecast ACIU Earnings & Move ACIU Dividends & DRIP ACIU Insiders & 13F ACIU Whale Options ACIU Profit Sankey ACIU News & Why